SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-13-002860
Filing Date
2013-05-31
Accepted
2013-05-30 18:24:15
Documents
6
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A form20fa.htm 20-F/A 15339
2 EXHIBIT 4.4 exhibit4-4.htm EX-4.4 146166
3 EXHIBIT 4.5 exhibit4-5.htm EX-4.5 554206
4 GRAPHIC exhibit4-5x78x1.jpg GRAPHIC 31865
5 GRAPHIC exhibit4-5x79x1.jpg GRAPHIC 15094
6 GRAPHIC exhibit4-5x80x1.jpg GRAPHIC 15368
  Complete submission text file 0001062993-13-002860.txt   803321
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 20-F/A | Act: 34 | File No.: 000-30082 | Film No.: 13883085
SIC: 2834 Pharmaceutical Preparations